New York, NY. Nixon Peabody LLP is pleased to have represented Sumitomo Corporation of Americas (Sumitomo), a subsidiary of the publicly traded Japanese corporation, Sumitomo Corporation, in a strategic equity investment in SHINE Technologies (SHINE).
SHINE is a fusion technology company engaged in the development of fusion-derived applications spanning medical isotopes, neutron imaging, nuclear waste recycling, and fusion energy.
The investment deepens a strategic partnership under which Sumitomo and SHINE are collaborating to commercialize fusion-derived products and technologies.
“We’re proud to support Sumitomo on transactions at the cutting edge of innovation, as it deepens its presence in the fusion technology space,” said Daniel Belostock, a partner in Nixon Peabody’s Corporate practice, who led the firm’s deal team.
The Nixon Peabody team included partners Jason Chimon, Christopher Grigg, and Harsh Parikh; counsel David Crosby; and associate Tim Sharkey.
See Sumitomo’s press release to learn more about this transaction.
